Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith a copy of letter being dispatched to the shareholders holding shares in physical mode, in compliance with the SEBI Circular No. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 dated May 07, 2024. The physical shareholders are requested to furnish their PAN, KYC and Nomination details for updation to the Registrar and Transfer Agent of the Company (RTA) i.e. M/s. MUFG Intime Private Limited.
RPGLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
RPG Life Sciences has informed stock exchanges that it has sent letters to shareholders holding shares in physical form, asking them to update their PAN, KYC details (mobile number, bank account, specimen signature, address) and nomination with the company's Registrar and Transfer Agent, MUFG Intime India Private Limited. This is a routine compliance filing under SEBI's May 7, 2024 circular. As per the SEBI mandate, physical shareholders who do not update these details will receive any future dividends only through electronic mode from April 1, 2024. Shareholders are also advised to convert their physical shares into demat form, as transfers of physical shares have been disallowed since April 1, 2019. The company has made the relevant forms and communications available on its website.
This is a routine regulatory compliance disclosure with no direct impact on the stock price or business operations. Physical shareholders of RPG Life Sciences should update their KYC details promptly to avoid any disruption in receiving dividends, and ideally convert their holdings to demat form for ease of trading.